Chris Metzger
Chris Metzger publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, on topics such as Peripheral Artery Disease Management, Coronary Interventions and Diagnostics and Acute Myocardial Infarction Research.
- World rank
- #1,643,151 of 7,710,434 ranked researchers
- Rank in United States
- #509,855 of 1,627,098
- Works
- 25
- Citations
- 601
- Citations per work
- 24.0
What does Chris Metzger research?
Chris Metzger's work is mostly in Medicine (87%), Engineering (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2286.7%
- Medicine2286.7%
- Everything else310.6%
- Physical Sciences12.7%
- Engineering12.7%
- 1Surgery47% of their works
- 2Pulmonary and Respiratory Medicine21% of their works
- 3Cardiology and Cardiovascular Medicine11% of their works
- 4Radiology, Nuclear Medicine and Imaging5% of their works
- 5Biomedical Engineering3% of their works
- 6Endocrinology, Diabetes and Metabolism3% of their works
Research topics
- Peripheral Artery Disease Management
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Vascular Procedures and Complications
- Cerebrovascular and Carotid Artery Diseases
- Aortic aneurysm repair treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Diagnosis and Treatment of Venous Diseases
Which keywords describe Chris Metzger's research?
The keywords of their largest research topics: Atherosclerosis, Percutaneous Coronary Intervention, Guidelines, Risk Factors, Angioplasty, Peripheral Arterial Disease, Coronary Stents and Myocardial Revascularization.
- Varicose Veins
- Chronic Venous Insufficiency
- Endovascular Repair
- Carotid Artery Stenosis
- Radial Access
- Femoral Access
- Myocardial Revascularization
- Peripheral Arterial Disease
- Risk Factors
- Percutaneous Coronary Intervention
- Atherosclerosis
- Guidelines
- Angioplasty
- Coronary Stents
- Acute Coronary Syndromes
- Myocardial Infarction
- Aneurysm Screening
- Endarterectomy
- Aspirin
- Clopidogrel
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Atherosclerosis262 topics
- Percutaneous Coronary Intervention203 topics
- Guidelines192 topics
- Risk Factors182 topics
- Angioplasty141 topic
- Peripheral Arterial Disease141 topic
- Coronary Stents121 topic
- Myocardial Revascularization121 topic
- Acute Coronary Syndromes51 topic
- Femoral Access51 topic
- Myocardial Infarction51 topic
- Radial Access51 topic
- Aneurysm Screening41 topic
- Carotid Artery Stenosis41 topic
- Endarterectomy41 topic
- Endovascular Repair41 topic
- Aspirin31 topic
- Chronic Venous Insufficiency31 topic
- Clopidogrel31 topic
- Varicose Veins31 topic
Where does Chris Metzger work?
Chris Metzger's main affiliation in the publication record is Ballad Health, United States.
How many publications and citations does Chris Metzger have?
OpenAlex counts 25 works and 601 citations for Chris Metzger, an h-index of 13, ranking #1,643,151 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Chris Metzger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.